First Results from Post-COVID Inpatient Rehabilitation
Overview
Authors
Affiliations
Background: COVID-19 is associated with various symptoms and psychological involvement in the long term. In view of the multifactorial triggering and maintenance of the post-COVID syndrome, a multimodal therapy with somatomedical and psychotherapeutic content is expedient. This paper compares the psychological stress of post-COVID patients and their course in rehabilitation to psychosomatic and psychocardiological patients.
Method: Observational study with control-groups and clinical, standardized examination: psychological testing (BDI-II, HELATH-49), 6-MWT as somatic parameter, two measurement points (admission, discharge). Sample characteristics, including work related parameters, the general symptom-load and the course of symptoms during rehabilitation are evaluated.
Results: At admission in all measures post-COVID patients were significantly affected, but less pronounced than psychosomatic or psychocardiological patients (BDI-II post-COVID = 19.29 ± 9.03, BDI-II psychosomatic = 28.93 ± 12.66, BDI-II psychocardiology = 24.47 ± 10.02). During rehabilitation, in all complaint domains and sub-groups, symptom severity was significantly reduced (effect sizes ranging from = .34 to = 1.22). Medium positive effects were seen on self-efficacy ( = .69) and large effects on activity and participation ( = 1.06) in post-COVID patients. In the 6-MWT, the walking distance improved by an average of 76.43 ± 63.58 meters ( = 1.22). Not a single patient deteriorated in walking distance, which would have been a possible sign of post exercise malaise (PEM).
Conclusion: Post-COVID patients have a slighter psychological burden as psychocardiological or psychosomatic patients. Although rehabilitation is not curative, post-COVID patients benefit significantly from the interventions and there were no signs of PEM.
Braun J Z Rheumatol. 2025; .
PMID: 39888379 DOI: 10.1007/s00393-024-01604-w.
Braun J Z Rheumatol. 2025; .
PMID: 39888378 DOI: 10.1007/s00393-024-01603-x.
Zimmermann-Schlegel V, Gronewold N, Stengel S, Hartmann M, Merle U, Friederich H Front Psychiatry. 2025; 15:1500210.
PMID: 39742330 PMC: 11687220. DOI: 10.3389/fpsyt.2024.1500210.
Gardiner L, Young H, Drover H, Morgan-Selvaratnam E, Natt M, Smith N Eur Respir Rev. 2024; 33(174).
PMID: 39603665 PMC: 11600128. DOI: 10.1183/16000617.0123-2024.
Pawlik M, Rinneberg G, Koch A, Meyringer H, Loew T, Kjellberg A Eur Arch Psychiatry Clin Neurosci. 2024; 274(8):1797-1817.
PMID: 39545965 PMC: 11579208. DOI: 10.1007/s00406-024-01911-y.